H. A. Braun et al. / Tetrahedron Letters 46 (2005) 2551–2554
2553
ology20 which provides access to the diastereomer when
the nitrogen is dibenzylated. The substrate controlled
diastereoselectivity provides straightforward access to
important intermediates of peptidomimetics. The chiral
induction by additional ligands is subject to ongoing
investigations.
R
R
CH2I2 / iPrMgCl
(5 equiv), THF
Z
Val Leu
N
Z
Val Leu
N
I
H
H
-78 ˚C, 15 min
0˚C, 1-2 h
O
OH
7a: R = iBu
7b: R = Bn
7c: R = sBu
7d: R = iPr
8a: R = iBu (82%)
8b: R = Bn (77%)
8c: R = sBu (86%)
8d: R = iPr (87%)
Acknowledgements
CHI3 / iPrMgCl
(5 equiv), THF
I
This work was supported by the Deutsche Forschungs-
gemeinschaft (SPP1085 SCHM1012-3) and the EU
contract LSHM-CT-2003-503330 (APOPIS).
Z
Val Leu
N
Z
Val Leu
N
I
-78 ˚C, 15 min
0˚C, 2 h
H
H
O
OH
7d
9 (77%)
Scheme 4.
Supplementary data
After these initial experiments we addressed the
iodomethylation of peptide aldehydes, which are impor-
tant intermediates for the synthesis of protease inhibi-
tors. The deprotonation of the acidic amides required
5-fold excess of the reagent. This was not a nuisance, be-
cause the deprotonation froze the configuration of the
P1–P3 positions of the tripeptide mimetics 7a–d. The
aldehydes were used as 3:1 mixtures of diastereomers,
as obtained from the oxidation of alcohols by IBX in
DMSO, followed by aqueous work up. The iodomethyl-
ation and diiodomethylation provided the compounds
8a–d and 9 (Scheme 4), apparently without epimeriza-
tion of the P1 position as judged by HPLC. The diaste-
reoselectivity of the reaction was always better than 2:1
as judged by HPLC.
Supplementary data associated with this article can be
References and notes
1. Fairlie, D. P.; Tyndall, J. D. A.; Reid, R. C.; Wong, A. K.;
Abbenante, G.; Scanlon, M. J.; March, D. R.; Bergman,
D. A.; Chai, C. L. L.; Burkett, B. A. J. Med. Chem. 2000,
43, 1271.
2. Powers, J. C.; Asgian, J. L.; Ekici, O. D.; James, K. E.
Chem. Rev. 2002, 102, 4639.
3. Schmidt, B. ChemBioChem 2003, 4, 366.
4. Wang, D.; Schwinden, M. D.; Radesca, L.; Patel, B.;
Kronenthal, D.; Huang, M.-H.; Nugent, W. A. J. Org.
Chem. 2004, 69, 1629.
The diastereoselectivity of the iodomethylation was
investigated for the phenylalanine derived aldehyde 10
(Scheme 5). The conversion into b-iodoalcohol 11 was
followed by substitution of the iodide with diethylamine.
The product 12 was deprotected and the resulting amino
alcohol was treated with triphosgene to give oxazolidi-
none 13 and care was taken not to separate the
diastereomers.
´
´
5. Fernandez-Megıa, E.; Iglesias-Pintos, J. M.; Sardina, F. J.
J. Org. Chem. 1997, 62, 4770.
´
6. Concellon, J. M.; Llavona, L.; Bernad, P. L., Jr. Tetra-
hedron 1995, 51, 5573.
7. (a) Entmayr, P.; Ko¨brich, G. Chem. Ber. 1976, 109, 2175;
(b) Taguchi, H.; Yamamoto, H.; Nozaki, H. J. Org. Chem.
1974, 96, 3010.
´
8. (a) Concellon, J. M.; Rodriguez-Solla, H.; Bardales, E.;
Huerta, M. Eur. J. Org. Chem. 2003, 1775; (b) Concellon,
´
NMR spectroscopy (13C NMR: c-effect,19 NOE) con-
firmed the relative configuration (anti/syn d.r. = 86:14).
This is in accordance with a chelation controlled Cram
transition state and complements the samarium method-
´ ´
J. M.; Bernad, P. L.; Perez-Andres, J. A. Tetrahedron Lett.
1998, 39, 1409.
9. (a) Imamoto, T.; Hatajima, T.; Takiyama, N.; Takeyama,
T.; Kamiya, Y.; Yoshizawa, T. J. Chem. Soc., Perkin
Trans. 1 1991, 3127; (b) Imamoto, T.; Takeyama, T.;
Koto, H. Tetrahedron Lett. 1986, 27, 3243; (c) Tabuchi, T.;
Inanaga, J.; Yamaguchi, M. Tetrahedron Lett. 1986, 27,
3891.
Ph
CH2I2 /
iPrMgCl
Ph
O
O
10. (a) Ko¨brich, G.; Fischer, R. H. Chem. Ber. 1968, 101,
3208; (b) Ko¨brich, G. Angew. Chem. 1967, 79, 15; Angew.
O
Ph
O
N
I
THF
Ph
O
N
H
H
OH
Chem., Int. Ed. Engl. 1967, 6, 41; (c) Ko¨brich, G.; Buttner,
¨
10
11
H.; Wagner, E. Angew. Chem. 1970, 82, 177; Angew.
Chem., Int. Ed. Engl. 1970, 9, 169.
HNEt2, EtOH,
reflux
11. Schulze, V.; Nell, P. G.; Burton, A.; Hoffmann, R. W.
J. Org. Chem. 2003, 68, 4546.
12. Muller, M.; Bro¨nstrup, M.; Knopff, O.; Schulze, V.;
¨
Ph
1.) H2, Pd/C,
EtOH
Ph
O
Hoffmann, R. W. Organometallics 2003, 22, 2931.
13. (a) Knochel, P.; Dohle, W.; Gommermann, N.; Kneisel, F.
F.; Kopp, F.; Korn, T.; Sapountzis, I.; Vu, V. A. Angew.
Chem., Int. Ed. 2003, 42, 4302; (b) Vu, V. A.; Marek, I.;
Polborn, K.; Knochel, P. Angew. Chem., Int. Ed. 2002, 41,
2.) triphosgene,
THF, reflux
HN
NEt2
Ph
O
N
NEt2
O
73% overall
H
O
OH
12
13
´
351; (c) Rottlander, M.; Boymond, L.; Berillon, L.;
Lepretre, A.; Varchi, G.; Avolio, S.; Laaziri, H.;
Scheme 5.
ˆ